Inova ends genetic tests that elicited FDA warning

Inova Health System will no longer offer a series of genetic tests after the Food and Drug Administration warned the system that it had illegally marketed them without the agency ’s required clearance. “The MediMap tests were intended to provide additional information to physicians in discussions with their patients regarding medication options,” reads an Inova statement, which said it began offering the tests as a tool for doctors based on industry guidelines, with t he understanding that the…
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news